2025-12-29 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the data you provided.

**1. Return Rate Comparison and Analysis**

*   **Company Overview:** Procter & Gamble Co. is a global consumer goods company offering a wide range of branded products.
*   **PG Cumulative Return:** 26.38%
*   **S&P 500 (VOO) Cumulative Return:** 103.21%
*   **Divergence:** -74.8 (Relative Divergence: 5.3)

**Analysis:**

*   PG has significantly underperformed the S&P 500 over the period covered by the cumulative return data.
*   The divergence is substantial (-74.8), indicating a large difference in performance.
*   The relative divergence of 5.3 suggests that PG's current underperformance is near the lower end of its historical range relative to the S&P 500. This implies that while PG has underperformed, it has not done so much worse than it has in the past.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 21.0%  | 7.9%   | -8.0%   | 0.0    | 215.0  |
| 2016-2018  | 9.0%   | 67.3%  | -6.0%   | 0.1    | 215.1  |
| 2017-2019  | 24.0%  | 70.4%  | 2.0%    | 0.3    | 292.3  |
| 2018-2020  | 27.0%  | 78.8%  | 4.0%    | 0.4    | 325.7  |
| 2019-2021  | 41.0%  | 78.8%  | -5.0%   | 0.5    | 382.9  |
| 2020-2022  | 13.0%  | 79.4%  | 13.0%   | 0.6    | 354.7  |
| 2021-2023  | 26.0%  | 79.4%  | 24.0%   | 0.4    | 343.0  |
| 2022-2024  | 9.0%   | 79.4%  | -12.0%  | 0.4    | 392.4  |
| 2023-2025  | -18.0% | 80.1%  | -85.0%  | 0.1    | 338.8  |

*   **CAGR:** Varies significantly, from -18% to 41%. The recent trend shows decreasing CAGR.
*   **MDD:** Relatively high maximum drawdowns, indicating significant price volatility at times. The MDD is increasing over time.
*   **Alpha:** Fluctuates, reflecting periods of outperformance (positive alpha) and underperformance (negative alpha) relative to the market. The most recent alpha is severely negative.
*   **Beta:** Low beta values (0.0 to 0.6) suggest that PG's price is generally less sensitive to overall market movements.
*   **Cap(B):** Market Cap is varying between ~ 215B and 392B.

**2. Recent Stock Price Fluctuations**

*   **Close:** 144.74
*   **Previous Close:** 144.49
*   **Change:** 0.17
*   **5-day SMA:** 143.91
*   **20-day SMA:** 143.93
*   **60-day SMA:** 147.43

**Analysis:**

*   The current price is slightly above the 5-day and 20-day simple moving averages, indicating a possible short-term uptrend.
*   The current price is below the 60-day SMA, suggesting a potential longer-term downtrend or consolidation.
*   The small change from the previous close suggests relatively low volatility currently.

**3. RSI, PPO, and Hybrid Signal Analysis**

*   **Market Risk Indicator (MRI):** 1.0 (High Investment Recommended)
*   **RSI:** 52.97
*   **PPO:** 0.21
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.0 (+): 단기상승 (Short-term rise)
*   **Expected Return (%):** -0.5%

**Analysis:**

*   The high MRI suggests that the model considers PG to be a relatively safe investment currently.
*   RSI is at 52.97, indicating neutral momentum.
*   PPO is slightly positive.
*   The hybrid signal suggests a strong buy recommendation.
*   The short-term rise in relative divergence is a positive sign.
*   The negative expected return suggests the model is pessimistic about PG's longer-term performance compared to the S&P 500.

**4. Recent News & Significant Events**

The recent news headlines paint a mixed picture:

*   **Positive/Neutral:** Some articles discuss potential opportunities ("Procter & Gamble Stock Update: What Investors Need to Know"), and assess the historical performance ("How Good Has PG Stock Actually Been?").
*   **Negative:** Others highlight price pullbacks ("Opinions on Recent Price Pullback"), lowered holdings ("Greenwood Capital Associates LLC Lowers Stock Holdings"), and a recent 2-year low ("Why Procter & Gamble Stock Hit a 2-Year Low").

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.92)
*   **Target Price:** $168.95 (Average), $186.00 (High), $148.00 (Low)

**Analysis:**

*   The analyst consensus is generally positive, with a "Buy" rating.
*   The average target price suggests potential upside from the current price.
*   The lack of recent rating changes might indicate a period of uncertainty or lack of strong conviction among analysts.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출        |
|------------|--------|-------------|
| 2025-10-24 | 2      | 22.39 B$    |
| 2025-04-24 | 1.58   | 19.78 B$    |
| 2025-01-22 | 1.94   | 21.88 B$    |
| 2024-10-18 | 1.65   | 21.74 B$    |
| 2025-10-24 | 1.65   | 21.74 B$    |

**Analysis:**

*   Earnings per share (EPS) and revenue have fluctuated over the past few quarters.
*   Most recent quarter 2025-10-24 shows a higher EPS.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $22.39B    | 51.37%       |
| 2025-06-30   | $20.89B    | 49.11%       |
| 2025-03-31   | $19.78B    | 50.98%       |
| 2024-12-31   | $21.88B    | 52.39%       |
| 2024-09-30   | $21.74B    | 52.06%       |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-09-30   | $53.27B    | 8.92%     |
| 2025-06-30   | $52.01B    | 6.95%     |
| 2025-03-31   | $52.27B    | 7.21%     |
| 2024-12-31   | $51.17B    | 9.05%     |
| 2024-09-30   | $51.84B    | 7.64%     |

**Analysis:**

*   **Revenue:** Shows some fluctuation, with no clear upward trend.
*   **Profit Margin:** Relatively consistent, generally above 50%.
*   **Equity:** Gradually increasing over the past few quarters.
*   **ROE:** Fluctuates, indicating variations in the company's profitability relative to its equity. The most recent ROE of 8.92% is solid.

**7. Comprehensive Analysis (Summary)**

*   **Underperformance:** PG has significantly underperformed the S&P 500, but the relative divergence suggests this is within its historical range.
*   **Mixed Signals:** Technical indicators offer mixed signals. SMA indicate short-term uptrend, but longer downtrend. High MRI indicates positive sign, while negative Expected return is a concern.
*   **Analyst Optimism:** Analysts have a generally positive outlook, but news headlines highlight both positive and negative developments.
*   **Solid Fundamentals:** PG maintains relatively stable profit margins and a generally positive ROE, showcasing its strong fundamentals.
*   **Recent Weakness:** The recent 2-year low and negative Alpha for 2023-2025 are concerning and warrant further investigation.

**Overall Recommendation:**

The data presents a mixed outlook for PG. While fundamental indicators appear solid, the underperformance relative to the S&P 500, recent price weakness, and the negative long-term expected return should raise concerns. The buy hybrid signal and generally positive analyst rating, along with a strong MRI, add to the complexity.
I recommend:

*   **Proceed with caution.** Don't rush into any large positions.
*   **Monitor news and earnings closely.** Pay attention to upcoming financial releases and analyst commentary.
*   **Assess your risk tolerance.** PG may be suitable for investors with a long-term horizon and a lower risk tolerance, but other opportunities with higher growth potential may be more attractive for those seeking higher returns.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.